novo nordisk's wegovy reduces cardiovascular risk more than lilly's tirzepatide Outperforms in Reducing Major Adverse Events Novo Nordisk is slashing GLP-1

Mice with inflammatory bowel disease healed within days of orally ingesting the peptide

Here's what actually keeps a GLP-1 patient on program for 6 to 12 months: A structured check-in cadence, not "see you next month" Weigh-in and measurement touchpoints that create accountability between visits Automated encouragement timed to hit right before the typical plateau Proactive outreach before a patient's usual drop-off window, not after they've gone quiet Flexible, one-tap rebooking instead of a phone call nobody has time to make None of this is about better medicine

.,

Direct contact with a frozen surface is just as dangerous as heat exposure

It was concluded that the weekly dose of 2.4 mg administered for 68 weeks resulted in average weight loss outcomes of 14.9%

Propionyl-L-carnitine: a new compound in the metabolic approach to the treatment of effort angina